Lv1
20 积分 2025-01-15 加入
OP0032 Treatment of Refractory Systemic Lupus Erythematosus with Off-the-Shelf iPSC-derived Anti-CD19 CAR T-cell Therapy
1个月前
已关闭
Computational modeling and experimental validation of the interaction between tumor biomarker mesothelin and an engineered targeting protein with therapeutic activity
2个月前
已完结
A novel high‐affinity human monoclonal antibody to mesothelin
2个月前
已完结
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancer
2个月前
已完结
Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer
2个月前
已完结
Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients
2个月前
已完结
Computational modeling and experimental validation of the interaction between tumor biomarker mesothelin and an engineered targeting protein with therapeutic activity
2个月前
已完结
Mesothelin in solid tumors: biology, biomarker utility, and therapeutic targeting
2个月前
已完结
Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches
3个月前
已完结
Reflections on Advances in Cancer Research in 2025
3个月前
已完结
皖公网安备34019202002308
